Cancer-associated thrombosis is one of the leading causes of morbidity and mortality for cancer patients. It commonly occurs in patients with clinically active malignancy; however, there is a subset of patients where thrombosis can be the first manifestation of their cancer. This article outlines the etiology of this disease as well as describes the evaluation process and management of these patients. It also highlights the role of the interprofessional team in evaluating and treating patients with this condition.

**Objectives:**
- Describes the etiology of cancer-associated thrombosis
- Summarize the diagnostic examination process for cancer-associated thrombosis
- Reviews current guidelines for the treatment of cancer-associated thrombosis
- Outlines the importance of collaboration and communication amongst the interprofessional team to improve outcomes for cancer patients with thromboembolic disease, especially if they are receiving anticoagulation.